Effect of Preoperative Budesonide Inhalation on Arterial Blood Oxygenation and Intrapulmonary Shunt During OLV
NCT03394222 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2018-01-09
Summary
The purpose of this study is to conduct a randomized controlled trial to evaluate the effect of preoperative budesonide inhalation on arterial blood oxygenation and intrapulmonary shunt in patients received one-lung ventilation
Conditions
Interventions
- DRUG
-
preoperative budesonide inhalation
- DRUG
-
preoperative normal saline inhalation
Sponsors & Collaborators
-
Fujian Medical University Union Hospital
lead OTHER
Principal Investigators
-
Wenhua chen, M.D. · Fujian Medical University Union Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 45 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-07-31
- Primary Completion
- 2017-03-31
- Completion
- 2017-04-30
More Related Trials
-
Evaluate the Safety Profile of BGF MDI in Chinese Patients With COPD in Routine Clinical Practice
NCT04536402 ·Status: COMPLETED
-
Budesonide / Formoterol in Treatment of Exacerbations of COPD
NCT00239278 ·Status: COMPLETED ·Phase: PHASE2
-
Randomized Trial of Fluticasone in Bronchial Premalignancy
NCT00407264 ·Status: COMPLETED ·Phase: PHASE2
-
Inhaled BUDESONIDE/FORMOTEROL in Bronchiolitis Obliterans Following Stem Cell Transplantation
NCT01560689 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase IIb Trial of Pulmicort Turbuhaler (Budesonide)
NCT00175747 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Phase I Pharmacokinetic Study (BF-BLOCK)
NCT01423305 ·Status: COMPLETED ·Phase: PHASE1
-
The Role of Theophylline Plus Low-dose Formoterol-budesonide in Treatment of Bronchiectasis
NCT01769898 ·Status: COMPLETED ·Phase: PHASE4
-
A 24-week Study of Fluticasone Furoate/Vilanterol Inhalation Powder in Subjects of Asian Ancestry With COPD
NCT01376245 ·Status: COMPLETED ·Phase: PHASE3
-
A Scintigraphy Study of PT010 in COPD Patients
NCT03906045 ·Status: COMPLETED ·Phase: PHASE1
-
Ultra-long Acting Bronchodilator Therapy in Smoking Asthmatics
NCT02682862 ·Status: COMPLETED ·Phase: PHASE4
-
Stratified TreAtment to Reduce Risk in COPD
NCT04458636 ·Status: COMPLETED ·Phase: PHASE4
-
Bronchodilator Test in Mechanical Ventilated Chronic Obstructive Pulmonary Disease Patients
NCT02218398 ·Status: UNKNOWN ·Phase: NA
-
Effect of the Inhaled Triple Therapies Over the Small Airway in Biomass Exposure
NCT06571942 ·Status: RECRUITING ·Phase: PHASE4
-
Perioperative Inhaled Therapy in Carcinological Thoracic Surgery in Patients at High Risk of Postoperative Pulmonary Complications
NCT06865040 ·Status: RECRUITING ·Phase: NA
-
Safety & Efficacy of BCT197A2201 in COPD Patients Presenting With an Exacerbation
NCT01332097 ·Status: COMPLETED ·Phase: PHASE2
-
Studying Genes in Blood and Lung Fluid Samples From Patients With Chronic Obstructive Pulmonary Disease With or Without a Previous Diagnosis of Lung Cancer or With Asthma Treated With Budesonide and Formoterol
NCT00569712 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess the Efficacy and Safety of PT003, PT005, and PT001 in Subjects With Moderate to Very Severe COPD
NCT02343458 ·Status: COMPLETED ·Phase: PHASE3
-
Individualized Dosing Schedule of Inhaled Bronchodilator for Endotracheally Intubated COPD Patients
NCT01933984 ·Status: COMPLETED ·Phase: NA
-
Safety And Efficacy Of UK-432,097 In Chronic Obstructive Pulmonary Disease.
NCT00430300 ·Status: TERMINATED ·Phase: PHASE2
-
A Safety, Pharmacokinetic and Pharmacodynamic Study of PUR0200 in COPD Patients
NCT01921712 ·Status: COMPLETED ·Phase: PHASE1
-
Phase IV O2 Consumption Study in COPD Patients.
NCT02533505 ·Status: COMPLETED ·Phase: PHASE4
-
Safety, Tolerability and Preliminary Efficacy of Adipose Derive Stem Cells for Patients With COPD
NCT02161744 ·Status: TERMINATED ·Phase: PHASE1
-
The Effects of Inhaled Budesonide-formoterol-glycopyrronium in Moderate-to-severe COPD
NCT04675463 ·Status: UNKNOWN ·Phase: NA
-
Budesonide in Treating Patients With Lung Nodules at High Risk of Developing Lung Cancer
NCT00321893 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate the Safety of MN-221 in Subjects With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
NCT01013142 ·Status: COMPLETED ·Phase: PHASE1